# Riccardo Lencioni

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/riccardo-lencioni/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,234 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 83 |
| i10-index | 202 |
| Last Known Institution | University of Pisa |
| OpenAlex ID | https://openalex.org/A5053299889 |
| ORCID iD | https://orcid.org/0000-0002-8535-6449 |
| Works | 526 |

## Researcher papers

- [Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update](https://scholariq.org/papers/image-guided-tumor-ablation-standardization-of-terminology-and-reporting-3/)
- [Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) - Update 2008](https://scholariq.org/papers/guidelines-and-good-clinical-practice-recommendations-for-contrast-enhanced-2/)
- [Image-Guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update](https://scholariq.org/papers/image-guided-tumor-ablation-standardization-of-terminology-and-reporting-2/)
- [Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)](https://scholariq.org/papers/response-to-radiofrequency-ablation-of-pulmonary-tumours-a-prospective-intention/)
- [Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013](https://scholariq.org/papers/thermal-ablation-of-colorectal-liver-metastases-a-position-paper-by-an/)
- [Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study](https://scholariq.org/papers/durvalumab-with-or-without-bevacizumab-with-transarterial-chemoembolisation-in/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [MRI in cancer diagnosis](https://scholariq.org/topics/mri-in-cancer-diagnosis/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [University of Pisa](https://scholariq.org/institutions/university-of-pisa/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.